Currently, the world is facing the pandemic of a novel strain of beta‐coronavirus known as
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Acute respiratory distress …

Abstract Coronavirus disease-2019 (COVID-19) creates severe respiratory distress and
often a cascade of other systemic complications impacting several organ systems. The …

Background Hospitalized acutely ill medical patients are at risk for fatal and major
thromboembolic events. Whether use of extended-duration primary thromboprophylaxis can …

Background COVID-19 is associated with both venous and arterial thrombotic complications.
While prophylactic anticoagulation is now widely recommended for hospitalized patients …

Background Best practice for prevention, diagnosis, and management of venous
thromboembolism (VTE) in patients with coronavirus disease 2019 (COVID‐19) is unknown …

In 2014, the American Society of Hematology (ASH), in collaboration with the McMaster
University GRADE Centre, initiated the development of evidence-based clinical practice …

Patients with venous thromboembolism (VTE) comorbid renal insufficiency (RI) are at higher
risk of bleeding and thrombosis. Recommendations in guidelines on anticoagulation therapy …

Background Thromboprophylaxis extended after hospital discharge in medically ill patients
currently is not recommended by practice guidelines because of uncertainty about the …

Scarce data exist regarding the clinical sequelae of COVID-19 and/or the prevalence of
thromboembolic disease in asymptomatic patients. Surely, there is increased prevalence of …

Objectives: Identify the indications of rivaroxaban therapy. Describe the mechanism of action
of rivaroxaban. Outline the contraindications in a patient on rivaroxaban therapy. Review the …